Finch: Finch Therapeutics Group, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024

Finch Therapeutics Group, Inc. reported earnings results for the second quarter and six months ended June 30, 2024. For the second quarter, the company reported net loss was USD 4.83 million compared to USD 6.95 million a year ago. Basic loss per share from continuing operations was USD 3.01 compared to USD 4.33 a year ago. Diluted loss per share from continuing operations was USD 3.01 compared to USD 4.33 a year ago. For the six months, net loss was USD 8.71 million compared to USD 69.3 million a year ago. Basic loss per share from continuing operations was USD 5.42 compared to USD 43.21 a year ago. Diluted loss per share from continuing operations was USD 5.42 compared to USD 43.21 a year ago.